CLDN6 CAR-T cell therapy (BioNTech)
- Generic Name
- CLDN6 CAR-T cell therapy (BioNTech)
A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm
Phase 2
Not yet recruiting
- Conditions
- Testicular Germ Cell TumorExtragonadal Germ Cell Tumor
- Interventions
- Biological: CLDN6 CAR-T
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- BioNTech SE
- Target Recruit Count
- 150
- Registration Number
- NCT06940804
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath